| Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor | | homo-2-mer | 572-864 | 99.63 | 2×7YS; |
|
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | | homo-2-mer | 576-863 | 100.0 | 5×CL; 2×9VS; 1×MG; |
|
| Apo crystal structure of the MerTK kinase domain | | monomer | 571-862 | 98.5 | 5×CL; |
|
| Crystal structure of MerTK kinase domain in complex with LDC1267 | | monomer | 571-862 | 98.5 | 1×R6H; 3×CL; |
|
| Crystal structure of MerTK kinase domain in complex with UNC2025 | | monomer | 571-862 | 98.5 | 1×R6N; 4×CL; 2×DMS; |
|
| Crystal structure of MerTK kinase domain in complex with Merestinib | | monomer | 571-862 | 100 | 1×L1X; 3×CL; |
|
| MerTK kinase domain with type 1.5 inhibitor containing a di-methyl pyrazole group | | monomer | 571-862 | 98.51 | 1×VJZ; 4×CL; 1×DMS; |
|
| MerTK kinase domain in complex with purine inhibitor | | monomer | 571-862 | 98.5 | 1×S4Q; |
|
| Crystal structure of MerTK kinase domain in complex with Gilteritinib | | monomer | 571-862 | 98.5 | 1×C6F; 4×CL; 1×DMS; |
|
| MerTK kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole group | | monomer | 571-862 | 98.52 | 1×VK5; 4×CL; |
|
| MerTK kinase domain in complex with a type 2 inhibitor | | monomer | 571-862 | 98.49 | 1×S4T; |
|
| MerTK kinase domain with type 1 inhibitor from a DNA-encoded library | | monomer | 571-862 | 98.5 | 1×S4Z; |
|
| MerTK kinase domain in complex with a bisaminopyrimidine inhibitor | | monomer | 571-862 | 98.49 | 1×S4N; |
|
| MerTK kinase domain with type 1.5 inhibitor from a DNA-encoded library | | monomer | 571-862 | 98.5 | 1×S4W; |
|
| MerTK kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole group | | monomer | 571-862 | 98.51 | 1×VK2; 4×CL; 1×DMS; |
|
| Crystal structure of MerTK Kinase domain with BMS794833 | | monomer | 571-862 | 98.5 | 1×E0X; 4×CL; 1×DMS; |
|
| Crystal structure of MerTK in complex with a type 1.5 aminopyridine inhibitor | | monomer | 574-863 | 100 | 1×R6K; 6×CL; 2×EDO; |
|
| Kinase domain of MERTK in complex with compound 8 | | monomer | 575-863 | 100.0 | 2×EDO; |
|
| Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex … | | monomer | 575-863 | 100.0 | 1×OLP; |
|
| Fragment-based Lead Discovery of Indazole-based Compounds as AXL Kinase Inhibitors | | monomer | 575-863 | 99.62 | 1×E56; |
|
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | | monomer | 576-863 | 100.0 | 3×CL; 1×K0X; |
|
| MerTK kinase domain in complex with quinazoline-based inhbitor | | monomer | 576-863 | 100.0 | 1×S4E; 3×SO4; |
|
| Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex … | | monomer | 575-861 | 100.0 | 2×CL; 1×MG; 1×ADP; 1×GOL; |
|
| MerTK kinase domain with type 3 inhibitor from a DNA-encoded library | | monomer | 576-862 | 100.0 | 1×S5E; 2×CL; 4×EDO; |
|
| Crystal structure of the MerTK kinase domain with SA4488 | | monomer | 578-864 | 100.0 | 1×A1APF; 2×CL; |
|
| Catalytic Domain of the Proto-oncogene Tyrosine-protein Kinase MER | | monomer | 575-861 | 100.0 | 1×MG; 1×ANP; 1×BME; |
|
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | | monomer | 577-863 | 100.0 | 4×CL; 1×6Q1; |
|
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | | monomer | 577-863 | 100.0 | 1×CKJ; 1×CL; 2×CA; |
|
| MerTK kinase domain in complex with NPS-1034 | | monomer | 577-862 | 100.0 | 1×S4K; |
|
| Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692 | | monomer | 577-862 | 98.48 | 1×YR7; |
|
| MerTK in complex with small molecule inhibitor 6-{1-[6-(3-hydroxy-3-methylbutoxy)-1,3-benzoxazol-2-… | | monomer | 578-862 | 100.0 | 1×A1APH; 4×CL; |
|
| MerTK in complex with small molecule 6-{1-[([1,1'-biphenyl]-4-yl)carbamoyl]azetidin-3-yl}-3-[(1-met… | | monomer | 578-862 | 100.0 | 1×A1APG; 2×CL; |
|
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | | monomer | 577-861 | 100.0 | 4×CL; 1×MG; 1×MH7; |
|
| Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Me… | | monomer | 577-861 | 99.58 | 1×7AE; |
|
| Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Me… | | monomer | 578-861 | 99.58 | 1×79Y; |
|
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | | monomer | 580-863 | 100.0 | 3×CL; 1×4MH; |
|
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | | monomer | 578-861 | 100.0 | 5×CL; 1×YDJ; |
|
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | | monomer | 578-861 | 100.0 | 4×CL; 1×MG; 1×24K; |
|
| Solution structures of the fn3 domain of human Proto-oncogene tyrosine-protein kinase MER precursor | | monomer | 373-483 | 100 | |
|